Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$21.55 - $29.29 $77,838 - $105,795
-3,612 Reduced 18.15%
16,289 $353,000
Q4 2023

Feb 14, 2024

SELL
$23.64 - $30.27 $64,419 - $82,485
-2,725 Reduced 12.04%
19,901 $575,000
Q3 2023

Nov 13, 2023

SELL
$26.74 - $40.81 $34,013 - $51,910
-1,272 Reduced 5.32%
22,626 $605,000
Q2 2023

Jul 31, 2023

SELL
$28.52 - $40.7 $55,756 - $79,568
-1,955 Reduced 7.56%
23,898 $884,000
Q1 2023

May 10, 2023

SELL
$29.39 - $36.27 $241,732 - $298,320
-8,225 Reduced 24.14%
25,853 $807,000
Q4 2022

Feb 07, 2023

SELL
$29.23 - $40.28 $159,420 - $219,687
-5,454 Reduced 13.8%
34,078 $1.01 Million
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $186,035 - $312,708
-4,906 Reduced 11.04%
39,532 $1.51 Million
Q2 2022

Aug 12, 2022

SELL
$47.98 - $62.75 $41,214 - $53,902
-859 Reduced 1.9%
44,438 $2.42 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $21,585 - $41,615
433 Added 0.97%
45,297 $2.83 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $61,994 - $84,210
802 Added 1.82%
44,864 $4.51 Million
Q3 2021

Nov 15, 2021

SELL
$74.87 - $110.87 $213,903 - $316,755
-2,857 Reduced 6.09%
44,062 $3.96 Million
Q2 2021

Aug 13, 2021

SELL
$66.8 - $100.45 $631,393 - $949,453
-9,452 Reduced 16.77%
46,919 $4.33 Million
Q1 2021

May 14, 2021

BUY
$59.3 - $183.85 $610,197 - $1.89 Million
10,290 Added 22.33%
56,371 $5.45 Million
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $626,277 - $1.05 Million
20,196 Added 78.02%
46,081 $2.4 Million
Q3 2020

Nov 09, 2020

BUY
$15.89 - $50.51 $156,723 - $498,180
9,863 Added 61.56%
25,885 $1.04 Million
Q2 2020

Aug 13, 2020

SELL
$8.89 - $18.28 $942 - $1,937
-106 Reduced 0.66%
16,022 $256,000
Q1 2020

May 14, 2020

BUY
$6.75 - $19.75 $108,864 - $318,528
16,128 New
16,128 $174,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.